According to Deputy Director of the Department of Health Nguyen Dinh Hung, antibiotics are an important weapon in treatment; therefore, in hospitals, doctors and pharmacists coordinate in prescribing drugs, providing drug information, and using drugs safely and effectively for patients, helping to increase treatment effectiveness, reduce costs, and control the increase in antibiotic resistance.
Strengthening antibiotic use management in patients
At Duc Giang General Hospital, the hospital director said that the consumption of priority antibiotics only accounted for 17.77% of antibiotics used inpatients at this hospital in the first 6 months of this year, the lowest level in the capital's health sector. To achieve this result, the hospital has recently established an Antibiotic Use Management Board; deployed support for prescription warnings on software, applied information technology in drug dispensing, etc.
The hospital also regularly organizes professional training sessions to improve knowledge about the safe and rational use of drugs, antibiotic prescription, antibiotic prophylaxis, antibiotic selection, correct and effective timing of use, etc.
In particular, the hospital has applied information technology to design drug use models for each group of diseases, personalizing drug use.
According to the Ministry of Health, antibiotics that need to be prioritized for management include 2 groups: Group 1 is reserve antibiotics, belonging to one of the following cases: the last choice in the treatment of severe infections when previous antibiotic regimens have failed or responded poorly; the choice of treatment for infections suspected or with microbiological evidence of being caused by multi-resistant microorganisms; antibiotics for the treatment of severe infections caused by drug-resistant microorganisms, with a high risk of resistance if widely used, need to consider appropriate indications; highly toxic antibiotics need to monitor therapeutic concentrations through drug concentrations in the blood, or close clinical and laboratory monitoring to minimize unwanted effects and toxicity.
Group 2 is antibiotics that are encouraged to implement a hospital-based monitoring program, including monitoring antibiotic consumption, monitoring the rate of bacterial resistance to antibiotics, and conducting drug use assessment studies to have appropriate interventions.
Source link
Comment (0)